# Efficacy and safety of vunakizumab in moderate-to-severe chronic plaque psoriasis: A randomized, double-blind, placebo-controlled phase 3 trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/efficacy-and-safety-of-vunakizumab-in-moderate-to-severe-chronic-plaque/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Kexiang Yan,Fuqiu Li,Xiaodong Bi,Ling Han,Zhenghua Zhang,Rixin Chen,Yu‐Ye Li,Litao Zhang,Xiao Hua Wang,Linfeng Li,Jianyun Lu,Aie Xu,Sen Yang,Yan Lü,Jianfang Sun,Zhiming Li,Xiaohong Zhu,Jiang Meiying,Siping Zhang,Wenqing Wang,Yanling Li,Zudong Meng,Hongyi Li,Kuanhou Mou,Xiuping Han,Shanshan Li,Aijun Chen,Xin Li,Donghua Liu,Chunlei Zhang,Chao Ji,Yu Wang,Hao Cheng,Xiaojing Cui,Xiaoyan Yao,Xiaoyan Bai,Guangchao Dong,Jinhua Xu |
| Citations | 28 |
| DOI | 10.1016/j.jaad.2024.09.031 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W4402839114 |
| PMID | 39332633 |
| Type | article |
| Year | 2024 |

## Paper authors

- [Wenqing Wang](https://scholariq.org/researchers/wenqing-wang/)

## Paper primary topic

- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)

## Paper topics

- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)
- [Spondyloarthritis Studies and Treatments](https://scholariq.org/topics/spondyloarthritis-studies-and-treatments/)
- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.